Examining Age-Specific Breast and Ovarian Cancer Risk Among BRCA Carriers
BY Katie Kosko
A recent study examined how age plays a factor in cancer risk for women with the BRCA1 or BRCA2 genetic mutation.
Study Shows Zejula's Benefit in Treating Ovarian Cancer
BY Darcy Lewis
Superior progression-free survival (PFS) was seen in patients with ovarian cancer who previously had a partial response (PR) to platinum-based therapy when they took Zejula (niraparib). This response was seen in patients with or without germline BRCA mutations, according to data from the ENGOT-OV16/NOVA trial presented at the 2017 ASCO Annual Meeting.
Pairing PARP Inhibitors With Other Drug Types the Next Frontier for BRCA-Mutated Ovarian Cancers
BY Beth Fand Incollingo
The idea of interfering with DNA’s self-repair capabilities has been at the heart of this decade’s progress in treating ovarian cancer, and the focus now is on combining PARP inhibitors with other types of therapies.
Sharon Bober on Asking Your Doctor About Sexual Health
BY Sharon Bober
Sharon Bober, PhD, discusses how patients can ask their doctors about sexual health.
Ilana Cass on Potential Consequences of Preventive Surgery
BY Ilana Cass, M.D.
Ilana Cass, M.D. of Cedars-Sinai Medical Center discusses some of the unknown potential side effects of preventive surgery for ovarian cancer. 
XRAYS Separates the Help from the Hype to Make Sense of Cancer Research in the News
BY Lauren M. Green
The program XRAYS is a resource to help patients, survivors and their loved ones make sense of the articles on hereditary cancer they see in the mainstream media and via social media platforms.
Survey Reveals Gaps in Needs of Patients with Ovarian Cancer
BY Allie Casey
The uncertainty that arises from an ovarian cancer diagnosis can be very stressful. A  recent study examined these feelings that many women with the disease are experiencing.
Avastin Benefit Varies By Ovarian Cancer Subtype
BY Jason Harris
A recent study found Avastin to be more effective in treating certain types of ovarian cancers.
Study Reveals Disparities in End-of-Life Care Among Patients With Ovarian Cancer
BY Jason Harris
Black and Latina women with ovarian cancer were less likely than white women to enroll in hospice care within the last 30 days.
Special Feature
Share Your Art
Talk about this article with other patients, caregivers, and advocates in the Ovarian CURE discussion group.
Search Cancer Drugs & Terms
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Ovarian Epithelial Cancer Treatment (PDQ®)
Expert-reviewed information summary about the treatment of ovarian epithelial cancer.
Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®)
Expert-reviewed information summary about the treatment of ovarian epithelial, fallopian tube, and primary peritoneal cancer treatment.
Ovarian Germ Cell Tumors Treatment (PDQ®)
Expert-reviewed information summary about the treatment of ovarian germ cell tumors.
Ovarian Low Malignant Potential Tumors Treatment (PDQ®)
Expert-reviewed information summary about the treatment of ovarian low-malignant potential tumors.
Prevention, Genetics, Causes
Information related to prevention, genetics, risk factors
Ovarian Cancer Prevention (PDQ®)
Expert-reviewed information summary about factors that may influence the risk of developing ovarian cancer and about research aimed at the prevention of this disease.
Screening and Testing
Information about methods of cancer detection including new imaging technologies, tumor markers, and biopsy procedures
Ovarian Cancer Screening (PDQ®)
Expert-reviewed information summary about tests used to detect or screen for ovarian cancer.